NasdaqCM - Nasdaq Real Time Price USD

Rein Therapeutics Inc. (RNTX)

1.7400
0.0000
(0.00%)
As of 1:44:22 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
28,112
28,112
15,348
27,647
26,605
Operating Income
-28,112
-28,112
-15,348
-27,647
-26,605
Net Non Operating Interest Income Expense
400
400
400
300
--
Other Income Expense
-36,600
-36,600
-728
318
441
Pretax Income
-64,312
-64,312
-15,676
-27,329
-26,164
Tax Provision
-1,544
-1,544
0
--
--
Net Income Common Stockholders
-62,883
-62,883
-15,732
-27,329
-26,164
Diluted NI Available to Com Stockholders
-62,883
-62,883
-15,732
-27,329
-26,164
Basic EPS
-3.51
-3.51
-3.42
-6.02
-5.89
Diluted EPS
-3.51
-3.51
-3.42
-6.02
-5.89
Basic Average Shares
17,938.8990
17,938.8990
4,598.7150
4,539.3180
4,440.3380
Diluted Average Shares
17,938.8990
17,938.8990
4,598.7150
4,539.3180
4,440.3380
Total Operating Income as Reported
-65,112
-65,112
-16,276
-27,647
-26,605
Total Expenses
28,112
28,112
15,348
27,647
26,605
Net Income from Continuing & Discontinued Operation
-62,883
-62,883
-15,732
-27,329
-26,164
Normalized Income
-27,064.0922
-27,064.0922
-15,004
-27,329
-26,164
Interest Income
400
400
400
300
--
Net Interest Income
400
400
400
300
--
EBIT
-28,112
-28,112
-15,348
-27,647
-26,605
EBITDA
-28,049
-28,049
-15,229
-27,478
-26,484
Reconciled Depreciation
63
63
119
169
121
Net Income from Continuing Operation Net Minority Interest
-62,883
-62,883
-15,732
-27,329
-26,164
Total Unusual Items Excluding Goodwill
-36,700
-36,700
-728
0
400
Total Unusual Items
-36,700
-36,700
-728
0
400
Normalized EBITDA
8,651
8,651
-14,501
-27,478
-26,484
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-881.0922
-881.0922
0
0
0
12/31/2021 - 6/29/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ACTU Actuate Therapeutics, Inc. Common stock
10.10
+2.02%
 
CUE Cue Biopharma, Inc.
0.7500
-2.34%
 
RNXT RenovoRx, Inc.
1.0700
+2.88%
 
INAB IN8bio, Inc.
0.1602
-4.58%
 
COYA Coya Therapeutics, Inc.
6.20
-0.16%
 
DNTH Dianthus Therapeutics, Inc.
19.84
-3.81%
 
4587.T PeptiDream Inc.
1,916.50
+1.16%
 
NMTRQ 9 Meters Biopharma, Inc.
0.0001
0.00%
 
4565.T Nxera Pharma Co., Ltd.
876.00
-0.23%
 
CGTX Cognition Therapeutics, Inc.
0.3057
-7.36%